Recombinant human interferon γ: Adverse effects in high-risk stage I and II cutaneous malignant melanoma

Frank L. Meyskens, Kenneth Kopecky, Michael Samson, Evan Hersh, John Macdonald, Howard Jaffe, John Crowley, Charles Coltman

Research output: Contribution to journal › Letter › peer-review

60 Scopus citations

Fingerprint

Dive into the research topics of 'Recombinant human interferon γ: Adverse effects in high-risk stage I and II cutaneous malignant melanoma'. Together they form a unique fingerprint.